Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
The butyrophilin (BTN) genes are a group of major histocompatibility complex (MHC)-associated genes that encode type I membrane proteins with 2 extracellular immunoglobulin (Ig) domains and an intracellular B30.2 (PRYSPRY) domain. Additionally we are shipping BTN3A1 Proteins (5) and and many more products for this protein.
Showing 10 out of 46 products:
Human Polyclonal BTN3A1 Primary Antibody for WB - ABIN657422
Smith, Knezevic, Ammann, Rhodes, Aw, Palmer, Mather, Trowsdale: BTN1A1, the mammary gland butyrophilin, and BTN2A2 are both inhibitors of T cell activation. in Journal of immunology (Baltimore, Md. : 1950) 2010
Show all 5 references for ABIN657422
Human Monoclonal BTN3A1 Primary Antibody for FACS - ABIN2664488
Compte, Pontarotti, Collette, Lopez, Olive: Frontline: Characterization of BT3 molecules belonging to the B7 family expressed on immune cells. in European journal of immunology 2004
Show all 2 references for ABIN2664488
Human Monoclonal BTN3A1 Primary Antibody for IF, WB - ABIN2663290
Wang, Henry, Distefano, Wang, Räikkönen, Mönkkönen, Tanaka, Morita: Butyrophilin 3A1 plays an essential role in prenyl pyrophosphate stimulation of human V?2V?2 T cells. in Journal of immunology (Baltimore, Md. : 1950) 2013
Show all 2 references for ABIN2663290
These findings support intracellular sensing of prenyl pyrophosphates by BTN3A1 rather than extracellular presentation.
Human gamma-delta T cells are activated by cytosolic interactions of BTN3A1 with soluble phosphoantigens and the cytoskeletal adaptor periplakin (show PPL Antibodies).
evidence that gene(s) on Chr6 in addition to BTN3A1 are mandatory for PAg (show PRDX1 Antibodies)-mediated activation of Vgamma9Vdelta2 T cells.
Ligand binding to the BTN3A1 B30.2 domain affects residues in the juxtamembrane region, suggesting ligand-induced conformational change.
These studies demonstrate that internal sensing of changes in pAg (show PRDX1 Antibodies) metabolite concentrations by BTN3A1 molecules is a critical step in Vgamma9Vdelta2 T cell detection of infection and tumorigenesis.
BTN3A1 represents an antigen-presenting molecule required for the activation of Vgamma9Vdelta2 T cells.
investigation of role of CD277 in activation/inactivation of T-lymphocytes: Data indicate that modulation of CD277 interaction (with agonists or blocking antibodies) with T-cell antigen receptor can modulate activation/inactivation of T-lymphocytes.
BTN3A1 is necessary for Vgamma9Vdelta2 activation and begin to unravel the extracellular events that occur during stimulation through the Vgamma9Vdelta2 T cell receptor.
CD277 triggering is not involved in CD16 (show CD16 Antibodies)- or NKp46 (show NCR1 Antibodies)-induced NK cell activation.
Results point to a role for CD277 up-regulated by microenvironmental signals in the acquisition of a regulatory phenotype by ovarian tumor-associated myeloid cells.
The butyrophilin (BTN) genes are a group of major histocompatibility complex (MHC)-associated genes that encode type I membrane proteins with 2 extracellular immunoglobulin (Ig) domains and an intracellular B30.2 (PRYSPRY) domain. Three subfamilies of human BTN genes are located in the MHC class I region: the single-copy BTN1A1 gene (MIM 601610) and the BTN2 (e.g., BTN2A1\\\\; MIM 613590) and BTN3 (e.g., BNT3A1) genes, which have undergone tandem duplication, resulting in 3 copies of each (summary by Smith et al., 2010
butyrophilin subfamily 3 member A1
, dJ45P21.3 (butyrophilin, subfamily 3, member A1)
, butyrophilin, subfamily 3, member A1
, butyrophilin subfamily 3 member A1-like